key topics
navigation
|
Single-Dose Syringe Garners FDA Approval
New Products:
Single-Dose Syringe Garners FDA Approval
-
|
|
Are you looking for new dosing administration options that facilitate convenience and compliance for patients? Look no further than the new 25 mg/0.5 mL single-use, pre-filled syringe, which has been approved by the Food and Drug Administration (FDA) for patients using etanercept (Enbrel, Amgen/Wyeth). Patients with rheumatoid arthritis, juvenile rheumatoid arthritis or ankylosing spondylitis may use the syringe, which is pre-filled with etanercept. According to Amgen/Wyeth, the new dosing vehicle has garnered an “Ease Of Use Commendation” from the Arthritis Foundation. In addition to the new 25 mg/0.5 mL prefilled syringe, Amgen/Wyeth also offers three other administration options including: the 50 mg/mL Enbrel (etanercept) SURECLICK™ autoinjector; the 25 mg multiple-use vial and the 50 mg prefilled syringe.
Product: Enbrel Prefilled Syringe (25 mg/0.5 mL)
Company: Amgen/Wyeth
Beating Foot And Ankle Pain
A new gel may help those who suffer from foot and ankle pain. Footcare Products recently introduced Synovium pain relieving gel. The company claims it is the first topical agent specifically formulated for foot and ankle pain relief. The gel reportedly offers enhanced absorption and effective pain relief within 30 seconds of application, according to the manufacturer. Synovium gel utilizes the ingredients of capsaicin and glucosamine. Footcare Products says the capsaicin in Synovium is effective in facilitating temporary relief of minor aches and pains in muscles, and joints due to strains and sprains. The glucosamine refreshes cartilage and lubricate joints, according to the manufacturer.
Product: Synovium
Company: Footcare Products, Inc. New Book Offers Insights On Prescribing Opioid Analgesics
Given the controversy over the use of opioid analgesics in pain management, clinicians may want to consider perusing a recently published reference book on the subject. “Avoiding Opioid Abuse While Managing Pain,” which is published by Sunrise River Press, may be beneficial for clinicians and physicians who must sort out clinical and ethical issues associated with prescribing these medications. The book is co-authored by Lynn R. Webster, MD and Beth Dove. Dr. Webster regularly lectures on the subject of preventing opioid abuse. He is board certified in anesthesiology and pain management. According to the book’s publisher, a portion of the profits from the book will be donated to the nonprofit organization LifeSource, which helps to control prescription drug abuse in America.
Product: Avoiding Opoid Abuse While Managing Pain: A Guide For Practitioners
Publisher: Sunrise River Press |
|
| Arthritis Practitioner - ISSN: 1 - Volume 3 - Issue 4 - July 2007 - Pages: - 42 | |
|
A complimentary CME Webcast Event
To register for this Web Archive program, click on Complimentary CME Webcast Event
This activity is for nurse practitioners, physician assistants, rheumatologists and internal medicine
physicians who treat patients with rheumatoid arthritis (RA).
Panelists/Lectures
"What You Should Know About Treating Early RA"
Nathan Wei, MD
Clinical Director
Arthritis and
Osteoporosis Center
Frederick, Md.
"A Closer Look At The Efficacy And Safety Of Combination Therapy With Anti-TNF Agents"
Philip Mease, MD
Clinical Professor
University of Washington
School of Medicine
Chief, Rheumatology Clinical Research
Swedish Hospital Medical Center
Seattle
"What The Studies Reveal About Emerging Therapies For RA"
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas,Tx.
This activity is supported by an educational grant from Genentech and Biogen Idec. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A complimentary CME Webcast Event
ON DEMAND
(Q&A with panelists to follow lectures)
To register for this Webcast program, click on Complimentary CME Webcast
This activity is geared to physicians, rheumatologists, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.
Agenda And Faculty
“Treating RA: The Shift To A More Aggressive Therapeutic Approach”
Linda Davis, MHS, PA-C
Assistant Professor
University Of North Texas Health Science Center
“What The Literature Reveals About Combination Therapy”
Kevin M. Latinis, MD, PhD
Division of Allergy, Clinical Immunology and Rheumatology
University of Kansas Medical Center
“New Biologic DMARDs: Can They Have An Impact?”
Salahuddin Kazi, MD
Chief of Rheumatology
Presbyterian Hospital
Dallas, Texas
This activity is supported by an educational grant from Bristol-Myers Squibb. The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A complimentary CME Web Archive Event
To register for this Web Archive program, click on Complimentary CME Web Archive Event
This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat osteoarthritis.
Agenda And Faculty
“A Closer Look At The Role Of Intraarticular Injections”
Frank Caruso, PA-C
Physician Assistant
Wake Forest University Baptist Medical Center
Winston-Salem, NC
“What The Literature Reveals About Viscosupplementation”
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, MD
“Mastering The Technique Of Intraarticular Injections”
Mike Rudzinski, PA-C
Physician Assistant
Buffalo Veterans Affairs Medical Center
Buffalo, NY
This activity is supported by an educational grant from Genzyme.
The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
A Complimentary CME Webcast Event
A Complimentary, On-Demand CME Webcast
To register for this Webcast program, click on Complimentary CME Webcast Event
This activity is geared to physicians, nurses, physician assistants and nurse practitioners who treat rheumatoid arthritis.
AGENDA and FACULTY
"Reviewing The Role of DMARDs In Treating RA"
Don Flinn, PA-C
Physician Assistant, McBride Clinic, Oklahoma City, Ok.
Vice-President, Society Of Physician Assistants In Rheumatology
"Assessing The Potential of Biologic Therapies"
Mark Genovese, MD
Associate Professor of Medicine
Division of Immunology And Rheumatology
Stanford University School Of Medicine
"What You Should Know About Infusion Therapy"
Nathan Wei, MD
Clinical Director
Arthritis and Osteoporosis Center
Frederick, Md.
This activity is supported by an educational grant from Bristol-Myers Squibb.
The activity is sponsored by the North American Center for Continuing Medical Education (NACCME).
|
Emerging Concepts In Treating Rheumatoid Arthritis
A Guide To Viscosupplementation For Osteoarthritis Knee Pain
A Guide To Infusion Therapy For Patients With Rheumatoid Arthritis